Biotech & Pharma

GSK to buy pulmonary hypertension biotech 35Pharma for $950M

27 sec read77 views0 listens

GlaxoSmithKline (GSK) acquired 35Pharma for $950 million to gain access to their pulmonary hypertension drug program, expanding GSK's therapeutic portfolio. This move is significant as it enhances GSK’s presence in specialized pharmaceutical markets and opens potential avenues for research into weight loss treatments. Content creators should note the growing interest of major pharma companies in niche biotech innovations, which may influence future healthcare content trends.

Read the full article at Endpoints News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

[AINews] The Unreasonable Effectiveness of Closing the Loop

Claude Code Remote Control rollout announced by @claudeai. Qwen 3.5 Medium Model Series released by @Alibaba_Qwen. Cursor agents now ship "demos not diffs" as per @cursor_ai. Karpathy discusses CLIs as agent-native interface on Twitter. Meta and AMD...

Ali Nemati

E-Commerce & RetailFeb 2530 sec read

How IKEA got closer to its shoppers with new small-format stores, Best Buy partnership

IKEA announced plans for four new U.S. stores in 2026, including its first small-format stores that blend elements of larger stores into a smaller space, aiming to increase accessibility; it also launched a partnership with Best Buy to integrate IKEA...

Ali Nemati

GamingFeb 2525 sec read

New Xbox Leadership Confirms No Microsoft Pressure to Increase AI Use

New Xbox leaders Asha Sharma and Matt Booty assure there will be no pressure for developers to use AI, emphasizing a commitment to maintaining high-quality content over technological trends. This stance is significant as it reassures content creators...

Ali Nemati

AI & Machine LearningFeb 2526 sec read

Why do deep technical searches still take hours - and what actually fixes them?

The article discusses the inefficiencies in technical research workflows due to fragmented information retrieval from PDFs and other sources, leading to incomplete understanding and delayed decision-making. It proposes a structured approach involving...

Ali Nemati

AI & Machine LearningFeb 2529 sec read

Why Deep Research Fails Fast (and How to Stop Burning Time)

The article discusses common pitfalls in integrating deep AI research into products, highlighting issues like treating research as a black-box process and over-relying on single models without proper retrieval checks. It emphasizes the importance of ...

Ali Nemati

GSK to buy pulmonary hypertension biotech 35Pharma for $950M

Related Articles

[AINews] The Unreasonable Effectiveness of Closing the Loop

How IKEA got closer to its shoppers with new small-format stores, Best Buy partnership

New Xbox Leadership Confirms No Microsoft Pressure to Increase AI Use

Why do deep technical searches still take hours - and what actually fixes them?

Why Deep Research Fails Fast (and How to Stop Burning Time)